lobbying_filings_raw: 87f7cf1c-e63d-4922-a33f-c542dd7be56c
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87f7cf1c-e63d-4922-a33f-c542dd7be56c | Q3 | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 134698 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2023 | third_quarter | 2023-10-17T10:06:03-04:00 | 160780.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/87f7cf1c-e63d-4922-a33f-c542dd7be56c/", "filing_uuid": "87f7cf1c-e63d-4922-a33f-c542dd7be56c", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2023, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/87f7cf1c-e63d-4922-a33f-c542dd7be56c/print/", "filing_document_content_type": "text/html", "income": "160780.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Kirby Miller", "dt_posted": "2023-10-17T10:06:03-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1625 Eye Street NW", "registrant_address_2": "Suite 600", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20006", "registrant": {"id": 29403, "url": "https://lda.senate.gov/api/v1/registrants/29403/", "house_registrant_id": 31286, "name": "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", "description": null, "address_1": "1625 Eye Street NW", "address_2": "Suite 600", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20006", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DAVID SPANGLER", "contact_telephone": "+1 202-429-9260", "dt_updated": "2026-01-15T16:02:44.446638-05:00"}, "client": {"id": 134698, "url": "https://lda.senate.gov/api/v1/clients/134698/", "client_id": 12, "name": "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-08"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65083, "prefix": null, "prefix_display": null, "first_name": "MARC", "nickname": null, "middle_name": null, "last_name": "SCHLOSS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 138418, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "KIRBY", "nickname": null, "middle_name": null, "last_name": "MILLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67610, "prefix": null, "prefix_display": null, "first_name": "DAVID", "nickname": null, "middle_name": "CHARLES", "last_name": "SPANGLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65083, "prefix": null, "prefix_display": null, "first_name": "MARC", "nickname": null, "middle_name": null, "last_name": "SCHLOSS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 138418, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "KIRBY", "nickname": null, "middle_name": null, "last_name": "MILLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67610, "prefix": null, "prefix_display": null, "first_name": "DAVID", "nickname": null, "middle_name": "CHARLES", "last_name": "SPANGLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65083, "prefix": null, "prefix_display": null, "first_name": "MARC", "nickname": null, "middle_name": null, "last_name": "SCHLOSS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 138418, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "KIRBY", "nickname": null, "middle_name": null, "last_name": "MILLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67610, "prefix": null, "prefix_display": null, "first_name": "DAVID", "nickname": null, "middle_name": "CHARLES", "last_name": "SPANGLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65083, "prefix": null, "prefix_display": null, "first_name": "MARC", "nickname": null, "middle_name": null, "last_name": "SCHLOSS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 138418, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "KIRBY", "nickname": null, "middle_name": null, "last_name": "MILLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67610, "prefix": null, "prefix_display": null, "first_name": "DAVID", "nickname": null, "middle_name": "CHARLES", "last_name": "SPANGLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65083, "prefix": null, "prefix_display": null, "first_name": "MARC", "nickname": null, "middle_name": null, "last_name": "SCHLOSS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 138418, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "KIRBY", "nickname": null, "middle_name": null, "last_name": "MILLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67610, "prefix": null, "prefix_display": null, "first_name": "DAVID", "nickname": null, "middle_name": "CHARLES", "last_name": "SPANGLER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 31286 | DC | DC | US | US | 0 | 0 | 992777 | normalized_name_state | 0.9 |